Overview

A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness, safety and tolerability of carisbamate treatment for the signs, symptoms, and impairment associated with Essential Tremor (ET) compared to placebo treatment. The secondary objective is to evaluate the effect of carisbamate treatment on indicators of affect and mood in patients who have ET compared to placebo treatment.
Phase:
Phase 2
Details
Lead Sponsor:
SK Life Science
SK Life Science, Inc.